080720 — Union Korea Pharm Co Income Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
Annual income statement for Union Korea Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 50,379 | 48,304 | 61,293 | 63,169 | 51,280 |
| Cost of Revenue | |||||
| Gross Profit | 19,352 | 15,239 | 24,019 | 20,897 | 14,231 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 61,353 | 59,452 | 59,994 | 75,380 | 73,716 |
| Operating Profit | -10,974 | -11,148 | 1,300 | -12,211 | -22,436 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -12,084 | -14,477 | 944 | -14,404 | -18,928 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -9,322 | -11,109 | -932 | -18,156 | -20,872 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -9,322 | -11,109 | -932 | -18,156 | -20,872 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -9,322 | -11,109 | -932 | -18,156 | -20,872 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1,386 | -1,386 | -129 | -1,898 | -2,080 |
| Dividends per Share |